Product logins

Find logins to all Clarivate products below.


Physician-Dispensed Cosmeceuticals – Market Insights – Europe (Supplemental)

The European physician-dispensed cosmeceutical market will expand strongly over the forecast period. Growth in the physician-dispensed cosmeceutical market will be driven by the high patient demand for aesthetic procedures, which is fueled by a strong aesthetic consciousness in Europe and online availability of physician-dispensed cosmeceuticals, although growth will be limited by the increasing availability of alternative, online retail channels for professional quality products.

This Medtech 360 Report provides high-level market metrics for physician-dispensed cosmeceuticals in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.

Table of contents


Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Europe
The diagnostic imaging system market in Europe is expected to experience gradual growth through 2034, supported by the continued rollout of advanced technologies, rising adoption of AI-driven…
Report
Aesthetic Injectables – Market Insights – Europe
The European aesthetic injectable market is on a strong growth trajectory. Product innovation and differentiated offerings from leading companies are expected to propel this expansion. The…
Report
Aesthetic Injectables – Market Insights – North America
The North American aesthetic injectable market is poised for sustained growth through 2034, driven by ongoing innovation and strong consumer demand. Leading global manufacturers continue to invest…
Report
Aesthetic Injectables – Market Insights – Asia Pacific
The Asia Pacific aesthetic injectable market will continue to expand through 2034, fueled by continuous innovation and the introduction of differentiated products by leading global and regional…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…